| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cohort study of controlled trials initially reported as abstracts
|
|
|
1989
|
10 |
3 |
p. 319-
1 p.
|
artikel
|
| 2 |
A coordinated system for randomizing patients to treatments and producing labels for clinical trials
|
Main, David
|
|
1989
|
10 |
3 |
p. 335-336
2 p.
|
artikel
|
| 3 |
A coordinating center's role in blinding of medication
|
Randall, A.M.Y.
|
|
1989
|
10 |
3 |
p. 338-
1 p.
|
artikel
|
| 4 |
A critique of recent research on the two-treatment crossover design
|
Fleiss, Joseph L.
|
|
1989
|
10 |
3 |
p. 237-243
7 p.
|
artikel
|
| 5 |
Adherence to Medication dosage schedules
|
|
|
1989
|
10 |
3 |
p. 333-334
2 p.
|
artikel
|
| 6 |
A distributed data entry system
|
Paul Beattie, W.
|
|
1989
|
10 |
3 |
p. 343-
1 p.
|
artikel
|
| 7 |
Advanced multicenter research (A.M.R.)
|
Rago, Salvatore
|
|
1989
|
10 |
3 |
p. 339-340
2 p.
|
artikel
|
| 8 |
Adverse drug reactions in clinical trials
|
Day, Philip
|
|
1989
|
10 |
3 |
p. 336-
1 p.
|
artikel
|
| 9 |
Adverse effects as primary endpoint: The hypren-trial experience
|
|
|
1989
|
10 |
3 |
p. 329-
1 p.
|
artikel
|
| 10 |
A focus-based database system for clinical trials
|
Glenn, Bruce
|
|
1989
|
10 |
3 |
p. 341-
1 p.
|
artikel
|
| 11 |
A local area network (LAN) based protocol tracking and information systems (PTIS) for cancer clinical trials
|
Multhauf, Phyllis M.
|
|
1989
|
10 |
3 |
p. 341-
1 p.
|
artikel
|
| 12 |
A multi-center phase I trial of chemotherapy in operable breast cancer
|
|
|
1989
|
10 |
3 |
p. 323-
1 p.
|
artikel
|
| 13 |
An approach to summarizing lab data from multicenter trials
|
|
|
1989
|
10 |
3 |
p. 317-
1 p.
|
artikel
|
| 14 |
An expert system for documenting DSM-III_R schizophrenia related diagnoses
|
Levine, Jerome
|
|
1989
|
10 |
3 |
p. 344-345
2 p.
|
artikel
|
| 15 |
An N of 1 service: How well does it work?
|
|
|
1989
|
10 |
3 |
p. 333-
1 p.
|
artikel
|
| 16 |
Announcement
|
|
|
1989
|
10 |
3 |
p. 356-
1 p.
|
artikel
|
| 17 |
A randomized, double-blind study of cemented (C) versus non-cemented (NC) hip prostheses (HP)
|
|
|
1989
|
10 |
3 |
p. 329-
1 p.
|
artikel
|
| 18 |
Are coding systems to handle text-data in clinical trials still necessary?
|
|
|
1989
|
10 |
3 |
p. 326-
1 p.
|
artikel
|
| 19 |
Are (placebo) run-in periods necessary in a drug trial in a chronic disorder?
|
Tijssen, J.G.P.
|
|
1989
|
10 |
3 |
p. 334-
1 p.
|
artikel
|
| 20 |
A sequential test for a phase II efficacy study
|
|
|
1989
|
10 |
3 |
p. 319-320
2 p.
|
artikel
|
| 21 |
A simple predictive model of leucopenia induced by cytotoxic anticancer drugs: The example of 4′-O-tetrahydropyranyl-doxorubicin (THP-ADM). Overview of 8 phase II studies conducted by the EORTC Clinical Screening Group (CSG)
|
|
|
1989
|
10 |
3 |
p. 317-318
2 p.
|
artikel
|
| 22 |
Assessing antiarrhythmic drug efficacy in considering all forms of arrhythmias simultaneously
|
Ulm, K.
|
|
1989
|
10 |
3 |
p. 347-
1 p.
|
artikel
|
| 23 |
Assessing the effect of stopping therapy
|
Anderson, Sharon
|
|
1989
|
10 |
3 |
p. 348-
1 p.
|
artikel
|
| 24 |
A standard phase IV protocol
|
Norton, John W.
|
|
1989
|
10 |
3 |
p. 351-
1 p.
|
artikel
|
| 25 |
A “weighted” rank sum test
|
Hallstrom, Alfred P.
|
|
1989
|
10 |
3 |
p. 345-
1 p.
|
artikel
|
| 26 |
Bayesian methods for analying treatment-by-subset interaction in clinical trials
|
|
|
1989
|
10 |
3 |
p. 331-
1 p.
|
artikel
|
| 27 |
Caffeine effects on calcium physiology in a crossover study: Issues in methods and analysis
|
Stegman, Mary Ruth
|
|
1989
|
10 |
3 |
p. 350-
1 p.
|
artikel
|
| 28 |
Choosing covariates in the analysis of clinical trials
|
|
|
1989
|
10 |
3 |
p. 320-
1 p.
|
artikel
|
| 29 |
Clinical judgement and centralized data management
|
Boone, Donna
|
|
1989
|
10 |
3 |
p. 339-
1 p.
|
artikel
|
| 30 |
Clinical trials can improve patient care and, at the same time contain costs
|
|
|
1989
|
10 |
3 |
p. 332-
1 p.
|
artikel
|
| 31 |
Communication strategies for multi-center clinical trials: The BARI hotline
|
Sutton-Tyrrell, Kim
|
|
1989
|
10 |
3 |
p. 343-
1 p.
|
artikel
|
| 32 |
Comparison of errors in body surface area and initial chemotherapy doses in five clinical trials
|
J. Palmer, Michael
|
|
1989
|
10 |
3 |
p. 351-
1 p.
|
artikel
|
| 33 |
Computerized follow-up program for large clinical trials
|
Ahn, Sylvie
|
|
1989
|
10 |
3 |
p. 336-
1 p.
|
artikel
|
| 34 |
Conducting a randomized cancer control trial in cooperative cancer treatment networks
|
|
|
1989
|
10 |
3 |
p. 325-
1 p.
|
artikel
|
| 35 |
Considerations for the meta-analysis of randomized clinical trials
|
Boissel, Jean-Pierre
|
|
1989
|
10 |
3 |
p. 254-281
28 p.
|
artikel
|
| 36 |
Criteria for bleeding events in a heart valve replacement trial
|
Giroux Klimek, M.
|
|
1989
|
10 |
3 |
p. 338-
1 p.
|
artikel
|
| 37 |
CTS: A clinical trials simulator
|
Wayne Taylor, D.
|
|
1989
|
10 |
3 |
p. 343-344
2 p.
|
artikel
|
| 38 |
Data editing and updating under centralized and distributed systems
|
Owen, Walter W.
|
|
1989
|
10 |
3 |
p. 342-
1 p.
|
artikel
|
| 39 |
Defining the universe of patients
|
|
|
1989
|
10 |
3 |
p. 324-
1 p.
|
artikel
|
| 40 |
Design and implementation of the optic neuritis treatment trial
|
Cleary, Patricia A.
|
|
1989
|
10 |
3 |
p. 350-
1 p.
|
artikel
|
| 41 |
Designing longitudinal studies in progressive renal disease
|
|
|
1989
|
10 |
3 |
p. 316-
1 p.
|
artikel
|
| 42 |
Design issues related to longitudinal studies of progressive dichotomous outcome measures that are subject to misdiagnosis
|
|
|
1989
|
10 |
3 |
p. 317-
1 p.
|
artikel
|
| 43 |
Design of a randomized clinical trial with slope as the outcome: The modification of diet in renal disease (MDRD) study
|
|
|
1989
|
10 |
3 |
p. 316-
1 p.
|
artikel
|
| 44 |
Design of a two-tiered clinical trial: Studies of left ventricular dysfunction
|
|
|
1989
|
10 |
3 |
p. 323-
1 p.
|
artikel
|
| 45 |
Design of the POSCH kidney stone trial
|
|
|
1989
|
10 |
3 |
p. 323-
1 p.
|
artikel
|
| 46 |
Development of a composite index as a primary outcome measure in a clinical trial
|
|
|
1989
|
10 |
3 |
p. 328-329
2 p.
|
artikel
|
| 47 |
Differences in categorization of morbidity and mortality event variables between study coordinators and endpoint review subcommittees in the Multicenter Diltiazem Post-infarction Trial (MDPIT)
|
|
|
1989
|
10 |
3 |
p. 328-
1 p.
|
artikel
|
| 48 |
Direct data entry using a digitizing tablet in psychopharmacology clinical trials
|
Levine, Jerome
|
|
1989
|
10 |
3 |
p. 344-
1 p.
|
artikel
|
| 49 |
Distributed data entry and electronic mail in the ONTT, a multicenter clinical trial
|
Campbell, Steven T.
|
|
1989
|
10 |
3 |
p. 342-343
2 p.
|
artikel
|
| 50 |
Distributed data entry in the AIDS clinical trials group
|
van der Horst, Charles
|
|
1989
|
10 |
3 |
p. 340-341
2 p.
|
artikel
|
| 51 |
Distributed randomization in multicenter clinical trials using microcomputer control
|
Youngblood, Marston E.
|
|
1989
|
10 |
3 |
p. 340-
1 p.
|
artikel
|
| 52 |
Doctors as pertinent information receptors
|
|
|
1989
|
10 |
3 |
p. 333-
1 p.
|
artikel
|
| 53 |
Dosimetry review process for head and neck (H&N) cancer trials conducted by radiation therapy oncology group (RTOG)
|
Pajak, Thomas F.
|
|
1989
|
10 |
3 |
p. 337-
1 p.
|
artikel
|
| 54 |
Eleventh annual meeting of the society for clinical trials
|
|
|
1989
|
10 |
3 |
p. 355-
1 p.
|
artikel
|
| 55 |
Ensuring the ethical conduct of cooperative clinical trials
|
|
|
1989
|
10 |
3 |
p. 332-
1 p.
|
artikel
|
| 56 |
Erratum
|
|
|
1989
|
10 |
3 |
p. 356-
1 p.
|
artikel
|
| 57 |
Estimating positive predictive value from a regression model: Screening with a non-invasive test
|
|
|
1989
|
10 |
3 |
p. 325-326
2 p.
|
artikel
|
| 58 |
Estimation of the coefficient of variation from laboratory analysis of split specimens
|
Connett, John E.
|
|
1989
|
10 |
3 |
p. 348-
1 p.
|
artikel
|
| 59 |
Estimation of time to complete prevention trials when data are monitored
|
|
|
1989
|
10 |
3 |
p. 318-
1 p.
|
artikel
|
| 60 |
Ethical considerations in the design and conduct of randomized clinical trials in patients with HIV infection
|
|
|
1989
|
10 |
3 |
p. 332-
1 p.
|
artikel
|
| 61 |
Ethics, power and signigicance testing in randomized play-the-winner trials: A review of one study
|
|
|
1989
|
10 |
3 |
p. 319-
1 p.
|
artikel
|
| 62 |
Eventcharts: Visualizing survival and other timed event data
|
Goldman, A.I.
|
|
1989
|
10 |
3 |
p. 346-
1 p.
|
artikel
|
| 63 |
Exact sample size calculations for 2 × 2 comparative trials when the outcome proportions are small
|
Thomas, Ronald G.
|
|
1989
|
10 |
3 |
p. 347-
1 p.
|
artikel
|
| 64 |
Free reprints to increase the return of follow-up questionnaires
|
Hughes, John R.
|
|
1989
|
10 |
3 |
p. 352-
1 p.
|
artikel
|
| 65 |
How many stratification factors can a study's randomization support?
|
|
|
1989
|
10 |
3 |
p. 331-
1 p.
|
artikel
|
| 66 |
Improving data quality on randomized clinical trials
|
|
|
1989
|
10 |
3 |
p. 327-
1 p.
|
artikel
|
| 67 |
Interim analysis through an independent data monitoring board
|
|
|
1989
|
10 |
3 |
p. 326-
1 p.
|
artikel
|
| 68 |
Iron supplementation during pregnancy—experiences of a randomized trial relying on health service personnel
|
Hemminki, Elina
|
|
1989
|
10 |
3 |
p. 290-298
9 p.
|
artikel
|
| 69 |
Issues in effeciency and reliability in trials using surrogate endpoints
|
|
|
1989
|
10 |
3 |
p. 328-
1 p.
|
artikel
|
| 70 |
Issues in the design and analysis of clinical trials of non-bronchodilating anti-asthma drugs
|
Uryniak, Thomas J.
|
|
1989
|
10 |
3 |
p. 335-
1 p.
|
artikel
|
| 71 |
Issues in the design and management of pre-hospital clinical trials: The MITI experience
|
|
|
1989
|
10 |
3 |
p. 333-
1 p.
|
artikel
|
| 72 |
Jackknifing the Cox regression estimator
|
|
|
1989
|
10 |
3 |
p. 330-
1 p.
|
artikel
|
| 73 |
Kendall's Tau and tests for trend in laboratory data
|
Wong, Rodney M.
|
|
1989
|
10 |
3 |
p. 347-
1 p.
|
artikel
|
| 74 |
Management of data queries and responses with a query database in a multicenter clinical trial with distributed data entry
|
|
|
1989
|
10 |
3 |
p. 327-328
2 p.
|
artikel
|
| 75 |
Management of multi-center trials: A comparison of investigator initiated studies and other administrative models
|
Dean Surbey, P.
|
|
1989
|
10 |
3 |
p. 337-
1 p.
|
artikel
|
| 76 |
Methodological quality of 290 randomized trials (RCTs) in the healing of duodenal ulcer
|
|
|
1989
|
10 |
3 |
p. 318-319
2 p.
|
artikel
|
| 77 |
Methods for detecting mislabeled data from multiple sites per patient
|
Maguire, Maureen G.
|
|
1989
|
10 |
3 |
p. 354-
1 p.
|
artikel
|
| 78 |
Monitoring compliance and contamination in a chemoprevention trial
|
Skingley, Peter
|
|
1989
|
10 |
3 |
p. 353-354
2 p.
|
artikel
|
| 79 |
Multiple corresponding analysis: An illustrative multivariate method applied to EORTC clinical trials
|
Van Glabbeke, M.
|
|
1989
|
10 |
3 |
p. 345-346
2 p.
|
artikel
|
| 80 |
Neglect of aged in clinical trials
|
Kannry, J.L.
|
|
1989
|
10 |
3 |
p. 348-
1 p.
|
artikel
|
| 81 |
Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error
|
|
|
1989
|
10 |
3 |
p. 330-331
2 p.
|
artikel
|
| 82 |
Operational aspects of the early termination of the multicenter trial of cryotherapy for retinopathy of prematurity
|
|
|
1989
|
10 |
3 |
p. 320-321
2 p.
|
artikel
|
| 83 |
Patient and Clinic factors predictive of missed visits and inactive status in a clinical trial
|
Blackhurst, Dawn W.
|
|
1989
|
10 |
3 |
p. 335-
1 p.
|
artikel
|
| 84 |
Permanent discontinuation of study drugs in long-term clinical trials
|
Sicurella, Jane
|
|
1989
|
10 |
3 |
p. 338-
1 p.
|
artikel
|
| 85 |
Permutation logrank test in controlled clinical trials
|
|
|
1989
|
10 |
3 |
p. 321-
1 p.
|
artikel
|
| 86 |
Philosophers assess randomized clinical trials: The need for dialogue
|
Miké, Valerie
|
|
1989
|
10 |
3 |
p. 244-253
10 p.
|
artikel
|
| 87 |
Progression of carotid atherosclerotic plaque as an endpoint in a clinical trial: The multicenter isradipine diuretic atherosclerosis study (MIDAS)
|
Byington, Robert P.
|
|
1989
|
10 |
3 |
p. 349-
1 p.
|
artikel
|
| 88 |
Proposed clinical trial of multivitamin use for the prevention of neural tube defects in China
|
|
|
1989
|
10 |
3 |
p. 322-
1 p.
|
artikel
|
| 89 |
Quality control of transfer of data in clinical trials
|
|
|
1989
|
10 |
3 |
p. 327-
1 p.
|
artikel
|
| 90 |
Quality of life in stage 2 breast cancer patients measured by a time trade off method
|
Kestle, J.
|
|
1989
|
10 |
3 |
p. 350-
1 p.
|
artikel
|
| 91 |
Quantifying ascertainment bias in vaccine efficacy trials
|
|
|
1989
|
10 |
3 |
p. 324-
1 p.
|
artikel
|
| 92 |
Randomization with a pocket-computer: A surrogate device when central randomization is not possible
|
|
|
1989
|
10 |
3 |
p. 318-
1 p.
|
artikel
|
| 93 |
Rationale and design of a randomized clinical trial on postinfarction survival and ventricular enlargement
|
|
|
1989
|
10 |
3 |
p. 329-330
2 p.
|
artikel
|
| 94 |
Recruitment in private versus academic primary care settings
|
Hughes, John R.
|
|
1989
|
10 |
3 |
p. 352-
1 p.
|
artikel
|
| 95 |
Recruitment in the lung health study (LHS)
|
Connett, John
|
|
1989
|
10 |
3 |
p. 353-
1 p.
|
artikel
|
| 96 |
Recruitment techniques in an ongoing trial
|
Hewson, Sheila A.
|
|
1989
|
10 |
3 |
p. 353-
1 p.
|
artikel
|
| 97 |
Sample sizes for constructing confidence intervals and testing hypotheses
|
Bristol, David R.
|
|
1989
|
10 |
3 |
p. 345-
1 p.
|
artikel
|
| 98 |
Site visit methodology in a VA cooperative study
|
Fye, Carol
|
|
1989
|
10 |
3 |
p. 337-
1 p.
|
artikel
|
| 99 |
Society for clinical trials board of directors, officers and committees 1989–1990
|
|
|
1989
|
10 |
3 |
p. 299-300
2 p.
|
artikel
|
| 100 |
Statistical analysis for studies with ordered hypothesis
|
Fenwick, J.W.
|
|
1989
|
10 |
3 |
p. 346-
1 p.
|
artikel
|
| 101 |
Statistical considerations in the early termination of the multicenter trial of cryotherapy for retinopathy of prematurity
|
|
|
1989
|
10 |
3 |
p. 320-
1 p.
|
artikel
|
| 102 |
Statistical design of the treatment of mild hypertension study (TOMHS)
|
Neaton, James D.
|
|
1989
|
10 |
3 |
p. 334-335
2 p.
|
artikel
|
| 103 |
Statistical methods for monitoring recruitment in a multicenter clinical trial
|
Michele Melia, B.
|
|
1989
|
10 |
3 |
p. 345-
1 p.
|
artikel
|
| 104 |
Stochastic curtailment methods and confidence intervals
|
|
|
1989
|
10 |
3 |
p. 321-
1 p.
|
artikel
|
| 105 |
Tenth annual meeting of the Society for Clinical Trials
|
|
|
1989
|
10 |
3 |
p. 301-315
15 p.
|
artikel
|
| 106 |
The analysis of a crossover design with several replicates per subject
|
Puterman, M.L.
|
|
1989
|
10 |
3 |
p. 348-
1 p.
|
artikel
|
| 107 |
The ASPIC trial: Telematics-assisted management of a multicenter clinical trial using a network of laptop personal computers
|
Wurm, Michel
|
|
1989
|
10 |
3 |
p. 341-
1 p.
|
artikel
|
| 108 |
The clinical research management information system: An institutional database for tracking clinical trials
|
Casper, Ephraim S.
|
|
1989
|
10 |
3 |
p. 342-
1 p.
|
artikel
|
| 109 |
The influence of a NIH funded study in a community hospital
|
Bealer, Joan
|
|
1989
|
10 |
3 |
p. 352-
1 p.
|
artikel
|
| 110 |
The Mid-Atlantic Oncology Program's comparison of two data collection methods
|
Jasperse, Dorcie M.
|
|
1989
|
10 |
3 |
p. 282-289
8 p.
|
artikel
|
| 111 |
The optimal use of a microcomputer system for distributed data entry
|
Hartigan, Pamela
|
|
1989
|
10 |
3 |
p. 340-
1 p.
|
artikel
|
| 112 |
The pop-parent software system: A distributed data processing and clinical trial management system for the NHLBI BARI
|
Amoroso, William P.
|
|
1989
|
10 |
3 |
p. 339-
1 p.
|
artikel
|
| 113 |
The problem of attributing deaths of nonadherers: The VA coronary bypass experience revisited
|
|
|
1989
|
10 |
3 |
p. 331-332
2 p.
|
artikel
|
| 114 |
The prophylactic penicillin (PROPS) trials
|
|
|
1989
|
10 |
3 |
p. 322-323
2 p.
|
artikel
|
| 115 |
The statistical component of Pfizer Pharmaceuticals PC-based Computer Assisted NDA (CANDA) system
|
|
|
1989
|
10 |
3 |
p. 326-
1 p.
|
artikel
|
| 116 |
The Studies of Left Ventricular Dysfunction (SOLVD) experience with a placebo run-phase
|
|
|
1989
|
10 |
3 |
p. 334-
1 p.
|
artikel
|
| 117 |
The use of factorial designs when the outcome variable is binary: What happens when low level interactions are present
|
|
|
1989
|
10 |
3 |
p. 323-324
2 p.
|
artikel
|
| 118 |
The use of registry as a complement to a clinical trial among patients with left-ventricular dysfunction (LVD)
|
|
|
1989
|
10 |
3 |
p. 325-
1 p.
|
artikel
|
| 119 |
The use of telemarketing techniques to enhance enrollment in clinical trials
|
Butt, Rodney W.
|
|
1989
|
10 |
3 |
p. 352-353
2 p.
|
artikel
|
| 120 |
To stop or not to stop: A case study
|
|
|
1989
|
10 |
3 |
p. 321-
1 p.
|
artikel
|
| 121 |
Toxicity grading systems for oncological trials
|
Franklin, H.R.
|
|
1989
|
10 |
3 |
p. 351-
1 p.
|
artikel
|
| 122 |
Training and certification of personnel in the asymptomatic carotid atherosclerosis study
|
Howard, Virginia J.
|
|
1989
|
10 |
3 |
p. 344-
1 p.
|
artikel
|
| 123 |
Use of ejection fraction as a surrogate endpoint for death in clinical trials of acute myocardial infraction
|
Harrelson, Lynn
|
|
1989
|
10 |
3 |
p. 349-
1 p.
|
artikel
|
| 124 |
Use of the triangular test in phase II cancer clinical trials
|
|
|
1989
|
10 |
3 |
p. 321-322
2 p.
|
artikel
|
| 125 |
Using a simple computer database to enhance clinic visit management
|
Frost, Philip H.
|
|
1989
|
10 |
3 |
p. 342-
1 p.
|
artikel
|
| 126 |
Using efficiency calculations to choose between logrank and Cox model analyses
|
|
|
1989
|
10 |
3 |
p. 330-
1 p.
|
artikel
|
| 127 |
Vertebral fracture as an end-point for clinical trials in osteoporosis: The reliability of digitizing techniques for vertebral area measurements
|
Tilley, B.C.
|
|
1989
|
10 |
3 |
p. 349-
1 p.
|
artikel
|
| 128 |
When to randomize?
|
|
|
1989
|
10 |
3 |
p. 324-
1 p.
|
artikel
|
Tijdschrift beschrijving